RespireRx Pharmaceuticals Inc (PK) (RSPI) Fundamentals

RespireRX Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, ADHD, spinal cord injury and other neurological conditions.
Share Info
Market Cap$ 538,174
Shares Authorized2,000,000,000
Shares Outstanding119,594,276
Shares Outstanding Date12/02/2020
Shareholder Count118
Shareholder Count Date10/13/2020
Float Date05/27/2022
Short Interest29,046
Short Interest Date11/30/2020
Reporting Info
Reporting StatusSEC Reporting
Audit StatusYes
AuditorHaskell & White LLP
Auditor Address300 Spectrum Drive
Suite 300
Irvine, California 92618
Auditor Websitehttp://
IR Firm-
IR Firm Address-
IR Firm Website-
Legal CounselDLA Piper - New Jersey
Legal Counsel Address-
Legal Counsel Website-
Fiscal Year End12/31
ADR Ratio-
Transfer AgentAmerican Stock Transfer & Trust Company
Transfer Agent Address6201 15th Avenue
Brooklyn, NY 11219
Depository Website
SHO Flag-
3210 Flag-
Company Info
Ticker SymbolUSOTC:RSPI
OTC Market TierPink Current
Security TypeCommon Stock
CIK Number0000849636
Address126 Valley Road
Suite C
Glen Rock, New Jersey 07452
Phone(201) 444-4947
Fax #415-887-7814
SIC Code / Description2834 / Pharmaceutical preparations
Key ExecutivesDir. - Kathryn MacFarlane
SVP, R&D - Richard Purcell, Jr.
CSO - Arnold Lippa
SVP, Product Dev. - David Dickason
CFO - Jeff Margolis
Number of Employees2
Incorporation StateDelaware
Incorporation CountryUSA
Incorporation Year1987

Your Recent History
RespireRx ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.